Following the ransomware attack last February 19, several of HAL Allergy’s IT systems have been restored. The recovered systems were gradually activated in recent weeks to enable deliveries to most…

Cyber security incident at allergen immunotherapy manufacturer and supplier HAL Allergy B.V. On the morning of Monday February 19, 2024, HAL Allergy was hit by a ransomware attack. HAL Allergy…

HAL Allergy and HOFFRICHTER (both companies of the Droege Group) are making a contribution to support the people in the Ukrainian war zones by donating respiratory ventilators ‘HOFFRICHTER Carat II…

Leiden (The Netherlands, 01.07.2021) – As of 1 July 2021, the Supervisory Board of the HAL Allergy Group has appointed Alex Huybens as Chief Executive Officer (CEO) and Member of…

Telephone counseling for all hospital staff members in the regions of Lombardei, Emilia Romagna, Veneto, Piedmont Rome, Italy, (March 26, 2020) – Today, HAL Allergy S.r.l. announced the start of…

Leiden, the Netherlands (June 27, 2019) – We are very proud that our CEO Dr. Harry Flore, has been honoured by His Majesty the King of the Netherlands for his…

Registration of SUBLIVAC® Birch and SUBLIVAC® Trees 40.000 AUN/ml in Germany accomplished Leiden, the Netherlands (14 August 2018) – HAL Allergy B.V. today announced the registration of SUBLIVAC® Birch 40.000 AUN/ml and SUBLIVAC® Trees 40.000 AUN/ml…

Wiesbaden, October 7, 2017 – On the occasion of the 12th German Allergy Congress in Wiesbaden, Germany, from October 5th  to 7th , 2017, the Internet platform of myAllergy (www.allergy.de)…